Viruses, variants and vaccines

Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.

Show simple item record

dc.contributor.author Cowan, Don A.
dc.contributor.author Burton, Stephanie G.
dc.contributor.author Rybicki, E.P.
dc.contributor.author Williamson, A.-L.
dc.contributor.author Dorrington, R.A.
dc.contributor.author Pepper, Michael Sean
dc.date.accessioned 2022-11-21T13:03:45Z
dc.date.available 2022-11-21T13:03:45Z
dc.date.issued 2021-05
dc.description.abstract The current SARS-CoV-2 pandemic has brought a number of major global clinical, sociological and economic issues into sharp focus. We address some of these issues, focusing on short-term factors such as virus mutations and vaccine efficacy, and also considering the longer-term implications of the current pandemic. We discuss societal responses to the presence of a pathogen that will probably remain in circulation for decades or longer, and to future new emergent viruses. en_US
dc.description.department Biochemistry en_US
dc.description.department Genetics en_US
dc.description.department Immunology en_US
dc.description.department Microbiology and Plant Pathology en_US
dc.description.librarian am2022 en_US
dc.description.sponsorship The South African Medical Research Council and the National Research Foundation. en_US
dc.description.uri http://www.samj.org.za en_US
dc.identifier.citation Cowan, D.A., Burton, S.G., Rybicki, E.P. et al. 2021, 'Viruses, variants and vaccines', South African Medical Journal, vol. 111, no. 5, pp. 409-411, doi : 10.7196/SAMJ.2021.v111i5.15578. en_US
dc.identifier.issn 0256-9574 (print)
dc.identifier.issn 2078-5135 (online)
dc.identifier.other 10.7196/SAMJ.2021.v111i5.15578
dc.identifier.uri https://repository.up.ac.za/handle/2263/88399
dc.language.iso en en_US
dc.publisher Health and Medical Publishing Group en_US
dc.rights © 2021 Health & Medical Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial Works License (CC BY-NC 3.0). en_US
dc.subject Vaccine en_US
dc.subject Virus en_US
dc.subject Pandemic en_US
dc.subject Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) en_US
dc.title Viruses, variants and vaccines en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record